Rosacea Subtype 1 (Erythematotelangiectatic) Completed Phase 2 Trials for Apremilast (DB05676)

Also known as: Erythematous Rosacea / Erythematous (Type One) Rosacea / Erythematotelangiectatic Rosacea / Erythemato-telangiectatic Rosacea / Acne rosacea, erythematous telangiectatic type

IndicationStatusPhase
DBCOND0058602 (Rosacea Subtype 1 (Erythematotelangiectatic))Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01045551Open Label Pilot Study of Apremilast in Treatment of RosaceaTreatment